• Je něco špatně v tomto záznamu ?

Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations

A. Gkourogianni, M. Andrew, L. Tyzinski, M. Crocker, J. Douglas, N. Dunbar, J. Fairchild, MF. Funari, KE. Heath, AA. Jorge, T. Kurtzman, S. LaFranchi, S. Lalani, J. Lebl, Y. Lin, E. Los, D. Newbern, C. Nowak, M. Olson, J. Popovic, Š. Pruhová, L....

. 2017 ; 102 (2) : 460-469.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc19013190

Grantová podpora
NV16-31211A MZ0 CEP - Centrální evidence projektů

Context: Heterozygous mutations in the aggrecan gene (ACAN) cause autosomal dominant short stature with accelerated skeletal maturation. Objective: We sought to characterize the phenotypic spectrum and response to growth-promoting therapies. Patients and Methods: One hundred three individuals (57 females, 46 males) from 20 families with autosomal dominant short stature and heterozygous ACAN mutations were identified and confirmed using whole-exome sequencing, targeted next-generation sequencing, and/or Sanger sequencing. Clinical information was collected from the medical records. Results: Identified ACAN variants showed perfect cosegregation with phenotype. Adult individuals had mildly disproportionate short stature [median height, -2.8 standard deviation score (SDS); range, -5.9 to -0.9] and a history of early growth cessation. The condition was frequently associated with early-onset osteoarthritis (12 families) and intervertebral disc disease (9 families). No apparent genotype-phenotype correlation was found between the type of ACAN mutation and the presence of joint complaints. Childhood height was less affected (median height, -2.0 SDS; range, -4.2 to -0.6). Most children with ACAN mutations had advanced bone age (bone age - chronologic age; median, +1.3 years; range, +0.0 to +3.7 years). Nineteen individuals had received growth hormone therapy with some evidence of increased growth velocity. Conclusions: Heterozygous ACAN mutations result in a phenotypic spectrum ranging from mild and proportionate short stature to a mild skeletal dysplasia with disproportionate short stature and brachydactyly. Many affected individuals developed early-onset osteoarthritis and degenerative disc disease, suggesting dysfunction of the articular cartilage and intervertebral disc cartilage. Additional studies are needed to determine the optimal treatment strategy for these patients.

Center for Personalized Medicine Children's Hospital of Los Angeles Los Angeles California 90027

Children's Hospital of Pittsburgh University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15237

Cincinnati Center for Growth Disorders Division of Endocrinology Cincinnati Children's Hospital Medical Center Cincinnati Ohio 70941

Cottage Children's Medical Center Santa Barbara California 93111

Department of Endocrinology and Diabetes Women's and Children's Hospital North Adelaide South Australia 5006 Australia

Department of Immunology Genetics and Pathology Science for Life Laboratory Uppsala University Uppsala 75236 Sweden

Department of Medical Sciences Örebro University and University Hospital Örebro 70185 Sweden

Department of Pediatrics 2nd Faculty of Medicine Charles University Prague and University Hospital in Motol Prague 11636 Czech Republic

Department of Pediatrics Oregon Health and Science University Portland Oregon 97239

Departments of Molecular and Human Genetics and

Division of Endocrinology Phoenix Children's Hospital Phoenix Arizona 85016

Division of Genetics Washington University St Louis Missouri 63130

Division of Pediatric Endocrinology Connecticut Children's Medical Center Hartford Connecticut 06106

Division of Pediatric Endocrinology Department of Women's and Children's Health Karolinska Institutet and Karolinska University Hospital Stockholm SE 171 76 Sweden

Division of Pediatric Endocrinology Department of Women's and Children's Health Karolinska Institutet and Karolinska University Hospital Stockholm SE 171 76 Sweden Section on Growth and Development Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health Bethesda Maryland 20892

Division of Pediatric Endocrinology Department of Women's and Children's Health Karolinska Institutet and Karolinska University Hospital Stockholm SE 171 76 Sweden Sunderby Hospital Sunderby 95442 Sweden

Divisions of Endocrinology and

El Rio Community Health Center Tucson Arizona 85745

Genetics Boston Children's Hospital Boston Massachusetts 02115

Hasbro Children's Hospital Providence Rhode Island 02903

Institute of Medical and Molecular Genetics and Skeletal Dysplasia Multidisciplinary Unit Hospital Universitario La Paz Universidad Autónoma de Madrid IdiPAZ and CIBERER ISCIII Madrid 20849 Spain

Institute of Medical and Molecular Genetics and Skeletal Dysplasia Multidisciplinary Unit Hospital Universitario La Paz Universidad Autónoma de Madrid IdiPAZ and CIBERER ISCIII Madrid 20849 Spain Department of Pediatrics Hospital Universitario Infanta Sofia Madrid 28703 Spain

Laboratorio de Biología Molecular Departamento de Genética Humana Instituto Nacional de Pediatría Insurgentes Cuicuilco Coyoacán 04530 México

Pediatric Endocrinology and Metabolism Baylor College of Medicine Houston Texas 77030

Section on Growth and Development Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health Bethesda Maryland 20892

Unidade de Endocrinologia do Desenvolvimento Disciplina de Endocrinologia Faculdade de Medicina da Universidade de São Paulo São Paulo 05508 020 Brazil

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19013190
003      
CZ-PrNML
005      
20190416074904.0
007      
ta
008      
190405s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1210/jc.2016-3313 $2 doi
035    __
$a (PubMed)27870580
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gkourogianni, Alexandra $u Division of Pediatric Endocrinology, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, Stockholm SE-171 76, Sweden.
245    10
$a Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations / $c A. Gkourogianni, M. Andrew, L. Tyzinski, M. Crocker, J. Douglas, N. Dunbar, J. Fairchild, MF. Funari, KE. Heath, AA. Jorge, T. Kurtzman, S. LaFranchi, S. Lalani, J. Lebl, Y. Lin, E. Los, D. Newbern, C. Nowak, M. Olson, J. Popovic, Š. Pruhová, L. Elblova, JB. Quintos, E. Segerlund, L. Sentchordi, M. Shinawi, EL. Stattin, J. Swartz, AG. Angel, SD. Cuéllar, H. Hosono, PA. Sanchez-Lara, V. Hwa, J. Baron, O. Nilsson, A. Dauber,
520    9_
$a Context: Heterozygous mutations in the aggrecan gene (ACAN) cause autosomal dominant short stature with accelerated skeletal maturation. Objective: We sought to characterize the phenotypic spectrum and response to growth-promoting therapies. Patients and Methods: One hundred three individuals (57 females, 46 males) from 20 families with autosomal dominant short stature and heterozygous ACAN mutations were identified and confirmed using whole-exome sequencing, targeted next-generation sequencing, and/or Sanger sequencing. Clinical information was collected from the medical records. Results: Identified ACAN variants showed perfect cosegregation with phenotype. Adult individuals had mildly disproportionate short stature [median height, -2.8 standard deviation score (SDS); range, -5.9 to -0.9] and a history of early growth cessation. The condition was frequently associated with early-onset osteoarthritis (12 families) and intervertebral disc disease (9 families). No apparent genotype-phenotype correlation was found between the type of ACAN mutation and the presence of joint complaints. Childhood height was less affected (median height, -2.0 SDS; range, -4.2 to -0.6). Most children with ACAN mutations had advanced bone age (bone age - chronologic age; median, +1.3 years; range, +0.0 to +3.7 years). Nineteen individuals had received growth hormone therapy with some evidence of increased growth velocity. Conclusions: Heterozygous ACAN mutations result in a phenotypic spectrum ranging from mild and proportionate short stature to a mild skeletal dysplasia with disproportionate short stature and brachydactyly. Many affected individuals developed early-onset osteoarthritis and degenerative disc disease, suggesting dysfunction of the articular cartilage and intervertebral disc cartilage. Additional studies are needed to determine the optimal treatment strategy for these patients.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a agrekany $x genetika $7 D053674
650    _2
$a antropometrie $x metody $7 D000886
650    _2
$a brachydaktylie $x genetika $7 D059327
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a mutační analýza DNA $x metody $7 D004252
650    _2
$a nanismus $x farmakoterapie $x genetika $7 D004392
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a růst $x genetika $7 D006128
650    _2
$a růstový hormon $x terapeutické užití $7 D013006
650    _2
$a heterozygot $7 D006579
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a degenerace meziobratlové ploténky $x genetika $7 D055959
650    _2
$a výhřez meziobratlové ploténky $x genetika $7 D007405
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a mutace $7 D009154
650    _2
$a osteochondritis dissecans $x vrozené $x genetika $7 D010008
650    _2
$a rodokmen $7 D010375
650    _2
$a fenotyp $7 D010641
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Andrew, Melissa $u Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 70941.
700    1_
$a Tyzinski, Leah $u Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 70941.
700    1_
$a Crocker, Melissa $u Divisions of Endocrinology and.
700    1_
$a Douglas, Jessica $u Genetics, Boston Children's Hospital, Boston, Massachusetts 02115.
700    1_
$a Dunbar, Nancy $u Division of Pediatric Endocrinology, Connecticut Children's Medical Center, Hartford, Connecticut 06106.
700    1_
$a Fairchild, Jan $u Department of Endocrinology and Diabetes, Women's and Children's Hospital, North Adelaide, South Australia 5006, Australia.
700    1_
$a Funari, Mariana F A $u Unidade de Endocrinologia do Desenvolvimento (LIM/42), Disciplina de Endocrinologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo 05508-020, Brazil.
700    1_
$a Heath, Karen E $u Institute of Medical and Molecular Genetics (INGEMM) and Skeletal Dysplasia Multidisciplinary Unit, Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, and CIBERER, ISCIII, Madrid 20849, Spain.
700    1_
$a Jorge, Alexander A L $u Unidade de Endocrinologia do Desenvolvimento (LIM/42), Disciplina de Endocrinologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo 05508-020, Brazil.
700    1_
$a Kurtzman, Tracey $u El Rio Community Health Center, Tucson, Arizona 85745.
700    1_
$a LaFranchi, Stephen $u Department of Pediatrics, Oregon Health and Science University, Portland, Oregon 97239.
700    1_
$a Lalani, Seema $u Departments of Molecular and Human Genetics and.
700    1_
$a Lebl, Jan $u Department of Pediatrics, Second Faculty of Medicine, Charles University in Prague and University Hospital in Motol, Prague 11636, Czech Republic.
700    1_
$a Lin, Yuezhen $u Pediatric Endocrinology and Metabolism, Baylor College of Medicine, Houston, Texas 77030.
700    1_
$a Los, Evan $u Department of Pediatrics, Oregon Health and Science University, Portland, Oregon 97239.
700    1_
$a Newbern, Dorothee $u Division of Endocrinology, Phoenix Children's Hospital, Phoenix, Arizona 85016.
700    1_
$a Nowak, Catherine $u Genetics, Boston Children's Hospital, Boston, Massachusetts 02115.
700    1_
$a Olson, Micah $u Division of Endocrinology, Phoenix Children's Hospital, Phoenix, Arizona 85016.
700    1_
$a Popovic, Jadranka $u Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15237.
700    1_
$a Pruhová, Štepánka $u Department of Pediatrics, Second Faculty of Medicine, Charles University in Prague and University Hospital in Motol, Prague 11636, Czech Republic.
700    1_
$a Elblova, Lenka $u Department of Pediatrics, Second Faculty of Medicine, Charles University in Prague and University Hospital in Motol, Prague 11636, Czech Republic.
700    1_
$a Quintos, Jose Bernardo $u Hasbro Children's Hospital, Providence, Rhode Island 02903.
700    1_
$a Segerlund, Emma $u Division of Pediatric Endocrinology, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, Stockholm SE-171 76, Sweden. Sunderby Hospital, Sunderby 95442, Sweden.
700    1_
$a Sentchordi, Lucia $u Institute of Medical and Molecular Genetics (INGEMM) and Skeletal Dysplasia Multidisciplinary Unit, Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, and CIBERER, ISCIII, Madrid 20849, Spain. Department of Pediatrics, Hospital Universitario Infanta Sofia, Madrid 28703, Spain.
700    1_
$a Shinawi, Marwan $u Division of Genetics, Washington University, St. Louis, Missouri 63130.
700    1_
$a Stattin, Eva-Lena $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala 75236, Sweden.
700    1_
$a Swartz, Jonathan $u Divisions of Endocrinology and.
700    1_
$a Angel, Ariadna González Del $u Laboratorio de Biología Molecular, Departamento de Genética Humana, Instituto Nacional de Pediatría, Insurgentes-Cuicuilco, Coyoacán 04530, México.
700    1_
$a Cuéllar, Sinhué Diaz $u Laboratorio de Biología Molecular, Departamento de Genética Humana, Instituto Nacional de Pediatría, Insurgentes-Cuicuilco, Coyoacán 04530, México.
700    1_
$a Hosono, Hidekazu $u Cottage Children's Medical Center, Santa Barbara, California 93111.
700    1_
$a Sanchez-Lara, Pedro A $u Center for Personalized Medicine, Children's Hospital of Los Angeles, Los Angeles, California 90027.
700    1_
$a Hwa, Vivian $u Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 70941.
700    1_
$a Baron, Jeffrey $u Section on Growth and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; and.
700    1_
$a Nilsson, Ola $u Division of Pediatric Endocrinology, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, Stockholm SE-171 76, Sweden. Section on Growth and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; and. Department of Medical Sciences, Örebro University and University Hospital, Örebro 70185, Sweden.
700    1_
$a Dauber, Andrew $u Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 70941.
773    0_
$w MED00002582 $t The Journal of clinical endocrinology and metabolism $x 1945-7197 $g Roč. 102, č. 2 (2017), s. 460-469
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27870580 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190416074929 $b ABA008
999    __
$a ok $b bmc $g 1392500 $s 1051495
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 102 $c 2 $d 460-469 $i 1945-7197 $m The Journal of clinical endocrinology and metabolism $n J Clin Endocrinol Metab $x MED00002582
GRA    __
$a NV16-31211A $p MZ0
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...